Variable | Study group ( n = 23) | Control group ( n = 23) | Hazard ratio (95% CI) | p value |
---|---|---|---|---|
Duration of MV | 1.663 (0.856–3.231)a | 0.115 | ||
Mean (SE, 95% CI) days | 13.61 (1.00, 11.66–15.56) | 17.77 (1.81, 14.21–21.33) | ||
Median (SE, 95% CI) days | 14 (2.38, 9.34–18.66) | 17 (2.23, 12.64–21.37) | ||
Ventilator-free daysb (median, IQR) | 14 (11–18) | 11 (3–16) | 0.172 | |
Duration of ICU stay | 2.182 (1.125–4.231)a | 0.015 | ||
Mean (SE, 95% CI) days | 17.6 3 (1.70, 14.30–20.97) | 25.87 (2.6, 20.81–30.94) | ||
Median (SE, 95% CI) days | 15 (3.19, 8.74–21.26) | 24 (1.82, 20.44–27.56) | ||
ICU-free daysc (median, IQR) | 13 (0–17) | 4 (0–8) | 0.028 | |
Support free daysd | ||||
Renal replacement therapy, day | 21 (0–24) (n = 7) | 23 (14–25) (n = 7) | 0.318 | |
Catecholamine, day | 26 (17.25–27) (n = 16) | 26 (18–27) (n = 14) | 0.728 | |
Nosocomial infections, n (%) | 10 (43.5) | 12 (52.2) | 0.768 | |
Mortality, n (%) | 3 (13.0) | 3 (13.0) | 1.000 |